PROCEPT BioRobotics Corporation (PRCT)

PROCEPT BioRobotics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	257.22	222.64	304.32	100.91	42.71
Cash & Cash Equivalents	257.22	222.64	304.32	100.91	42.71
Cash Growth	15.53%	-26.84%	201.58%	136.25%	-
Receivables	48.38	15.27	4.46	1.55	1.1
Inventory	39.76	28.54	13.15	6.92	6.28
Other Current Assets	5.21	6.18	4.24	0.88	0.64
Total Current Assets	350.57	272.63	326.17	110.26	50.74
Property, Plant & Equipment	48.99	32.14	8.32	12.92	8.27
Long-Term Investments	3.04	3.04	0.78	0	0
Goodwill and Intangibles	1.2	1.48	1.75	2.02	2.3
Other Long-Term Assets	0.92	0.05	0	0.78	0.69
Total Long-Term Assets	54.15	36.7	10.85	15.72	11.26
Total Assets	404.72	309.33	337.02	125.97	62
Accounts Payable	13.5	9.39	2.03	1.24	1.44
Deferred Revenue	5.66	2.86	1.03	0.23	0
Current Debt	1.68	2.13	2.11	6.26	0
Other Current Liabilities	25.09	20.92	11.08	6.79	5.35
Total Current Liabilities	45.93	35.29	16.24	14.53	6.79
Long-Term Debt	77.52	75.19	52	48.5	23.22
Other Long-Term Liabilities	0.52	1.78	1.7	1.98	2.75
Total Long-Term Liabilities	78.04	76.97	53.69	50.49	25.97
Total Liabilities	123.97	112.26	69.93	65.01	32.76
Total Debt	79.2	77.32	54.1	54.76	23.22
Debt Growth	2.44%	42.91%	-1.21%	135.80%	-
Retained Earnings	-454.57	-348.68	-261.52	-201.67	-148.65
Comprehensive Income	0.08	-0.01	-0.05	-0.01	0
Shareholders' Equity	280.75	197.07	267.09	-182.89	-143.84
Net Cash / Debt	178.02	145.32	250.22	46.15	19.49
Net Cash / Debt Growth	22.50%	-41.92%	442.25%	136.79%	-
Net Cash Per Share	3.77	3.27	15.18	12.60	8.83
Working Capital	304.64	237.34	309.93	95.73	43.95
Book Value Per Share	5.94	4.44	16.21	-49.93	-65.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).